CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
75 mg / 6 mL VFI™device
Likely dose
75 mg / 6 mL VFI™from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01978314
NCT01978314N/ACompleted
CompareCT.gov

A Single-Center Prospective Study Evaluating the FAST Measured Glomerular Filtration Rate (mGFR) Test™ in Adults With Preserved Kidney Function and Impaired Kidney Function With Comparison to Iohexol Clearance Methods

FAST BioMedical·interventional·Posted Nov 7, 2013·Updated Dec 12, 2017

In Brief

A clinical study evaluating 75 mg / 6 mL VFI™ for Chronic Kidney Disease and Acute Kidney Injury. Completed, enrolled 33 participants across 1 site.

Detailed Summary

This is a single site study designed to evaluate the FAST mGFR Test™ in healthy adult volunteers, patients with varying degrees of chronic kidney disease (CKD), and patients with acute kidney injury (AKI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease, Acute Kidney Injury
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 7, 2013
Enrollment StartAug 1, 2013
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 12.7 years ago

Interventions

75 mg / 6 mL VFI™device

Visible fluorescent injectate, a mixture of two different molecular weight carboxymethyl dextran molecules (5 kD and 150 kD) with different fluorescent dye molecules attached.